Organizations often assess the impact of quality, compliance and regulatory affairs functions as the potentially enormous cost of poor quality or non-compliance. Seen as cost-centres, these organizations are hard-pressed to demonstrate efficiency and effectiveness, while confronting increasingly tightening and globally differing guidelines. Faced with these challenges, how do best-in-class quality, compliance regulatory affairs organizations manage resources to drive performance? How do quality organizations streamline structure and operations to achieve process excellence? What are some tools and tactics for improving their quality organizations while mitigating risk? How do medical device, diagnostics or pharmaceutical regulatory affairs organizations build and leverage relationships with the FDA to expedite device or drug approvals?
Best Practices, LLC’s benchmarking reports enable executives to strengthen these functions through providing meaningful regulatory affairs metrics and proven quality management tactics. Providing cross-industry and industry-specific data, our benchmarking reports enable quality management organizations to optimize operations, institute risk management and mitigation programs, implement effective quality initiatives and achieve process excellence. Compliance and regulatory affairs organizations can use these reports to improve device or drug approval rate, harness emerging trends, sufficiently staff and support their initiatives.
To fulfill the requirements of its growing strategic role, the Quality, Compliance & Regulatory function needs to continuously re-invent itself by optimizing its overall capabilities, including:
Quality, Compliance & Regulatory Benchmarking Reports
View Benchmarking Research Methodology
-- Training & Development, Bayer
View More Testimonials